DLA Piper advised Hercules Capital in the transaction. Hercules Capital, Inc., a leading private credit fund focused on venture and growth lending, provided a secured loan...
Hercules Capital’s US$150 Million Term Loan Facility for NeueHealth
Heron Therapeutics’ Capital Credit Facility Agreement With Hercules Capital
Latham & Watkins advises on Heron Therapeutics’ working capital credit facility. Heron Therapeutics, Inc. (Heron), a commercial-stage biotechnology company focused on improving the lives of patients...
Tipalti’s $150 Million Growth Financing
Latham & Watkins and Gornitzky & Co. advise Hercules on the financing. Tipalti announced it has raised $150 million in incremental growth financing from JPMorgan Chase...
Kura Oncology’s $125 Million Financing Agreement
Latham & Watkins LLP represented Hercules Capital, Inc. in the transaction. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
Tricida’s $125 Million Debt Facility
Latham & Watkins LLP represented Hercules in the transaction. Tricida, Inc. (Nasdaq: TCDA) has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a...